You are viewing: US Mental Health Screening Market analysis
Part of: Mental Health Screening Market (Global)

The US Mental Health Screening Market was valued at $176.23 Million in 2023 and projected to reach to $340.35 Million by 2028, representing a compound annual growth rate of 11.6%. The US mental health screening market is poised for substantial growth through 2028, supported by increasing recognition of mental health as a critical component of overall healthcare.

US Mental Health Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Mental Health Screening Market Trends and Insights

  • This growth in the US is driven by increasing awareness of mental health conditions, rising prevalence of depression and anxiety disorders, and greater integration of screening tools into primary care settings across the country.
  • The US market benefits from robust healthcare infrastructure, favorable reimbursement policies, and significant investment in digital mental health solutions. In the US, the mental health screening market is experiencing accelerated adoption of both traditional and technology-enabled screening platforms.
  • The US healthcare system's shift toward preventive care and early intervention has positioned mental health screening as a critical component of comprehensive patient assessment.
  • By 2028, the US market is expected to see continued expansion driven by regulatory support, workplace mental health initiatives, and the growing acceptance of telehealth-based screening services throughout the nation..

Key Market Statistics

  • CAGR (2023-2028) 11.6% CAGR
  • Market Size, 2023 ~USD 176.23 Million
  • Forecast, 2028 ~USD 340.35 Million
  • Country US

US Mental Health Screening Market Overview

Market Valuation Growth :

The US mental health screening market reached $176.23 million in 2023 and is expected to grow to $340.35 million by 2028, nearly doubling in size over the five-year forecast period.

Strong CAGR Trajectory :

The US market is expanding at an 11.6% compound annual growth rate, driven by heightened awareness of mental health conditions and increased adoption of screening protocols in healthcare facilities.

Primary Care Integration :

Mental health screening tools are increasingly being integrated into primary care settings across the US, enabling earlier detection and intervention for depression, anxiety, and other mental health disorders.

Rising Prevalence Drivers :

Growing prevalence of depression and anxiety disorders in the US population, combined with reduced stigma and improved insurance coverage, is accelerating demand for standardized mental health screening solutions.

US Mental Health Screening Market Dynamics

  • Healthcare providers are prioritizing early detection and intervention, with screening becoming standard practice in primary care, emergency departments, and specialty clinics.
  • Technological advancements in digital screening tools and telehealth integration are expanding accessibility across diverse populations. Regulatory support and insurance reimbursement improvements are further catalyzing market expansion.
  • The convergence of rising mental health awareness, workforce shortages driving efficiency needs, and patient demand for comprehensive care positions the US market for sustained double-digit growth.
  • Investment in mental health infrastructure and screening capabilities will remain a priority for healthcare systems nationwide..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Key Takeaways

    • The US mental health screening market is valued at $176.23 million in 2023 and will nearly double to $340.35 million by 2028.
    • The US market is growing at an 11.6% CAGR, driven by increased mental health awareness and integration into primary care.
    • Digital and telehealth-based screening solutions are rapidly gaining adoption across the US healthcare system.
    • Workplace mental health programs and preventive care initiatives are key growth catalysts in the US market.

    Mental Health Screening Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment COGNITIVE (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 12.2% from 2023 to 2028
    Largest Segment ADULTS (AGE 19-64 YEARS) (Age Group)
    Market Size Base Year (Billions) ~USD 0.9 (2023)
    Revenue Forecast (Billions) ~USD 1.6 (2028)
    Segments Covered Application, Type, Screening Method, Technology, Age Group, Setting

    US Mental Health Screening Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Application

    • Behavioral Disorders
    • Cognitive
    • Cognitive Disorders
    • Physiological Disorders
    • Psychiatric Disorders

    By Type

    • Aggression
    • Alzheimer'S Disease
    • Anxiety
    • Attention Deficit Hyperactivity Disorder (Adhd)
    • Beck Depression Inventory (Bdi)
    • Bipolar Disorder
    • Cognitive Impairment
    • Dementia
    • Depression
    • Diagnostic Interview For Psychological Distress (Dipd)
    • Dissociative Disorder
    • Eating Disorder
    • Generalized Anxiety Disorder-7 (Gad-7)
    • Hamilton Anxiety Rating Scale (Ham-A)
    • Hyperactivity
    • Mini International Neuropsychiatric Interview (Mini)
    • Obsessive Compulsive Disorder (Ocd)
    • Other Behavioral Disorders
    • Other Clinical Interviews
    • Other Cognitive Disorders
    • Other Physiological Disorders
    • Other Psychiatric Disorders
    • Other Self-Reported Questionnaires & Surveys
    • Patient Health Questionnaire-12 (Phq-12)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Psychotic Disorder
    • Schizophrenia
    • Self-Harm
    • Sleep Disorders
    • Social Withdrawal
    • Structured Clinical Interview For Dsm (Scid)
    • Structured Clinical Interviews For Dsm (Scid)
    • Substance Abuse
    • Yale-Brown Obsessive Compulsive Scale (Y-Bocs)

    By Screening Method

    • Biomarker Testing
    • Clinical Interviews
    • Observation-Based Assessments
    • Self-Reported Questionnaires & Surveys

    By Technology

    • AI-Based Screening Tools
    • Continuous Monitoring Wearable Devices
    • Remote Mental Health Platforms
    • Self-Screening Mhealth Apps
    • Telehealth & Virtual Care Solutions

    By Age Group

    • Adults (Age 19-64 Years)
    • Children & Adolescents (0-18 Years)
    • Children & Adolescents (Age 0-18 Years)
    • Seniors (Age 65 And Above)

    By Setting

    • Clinical Settings
    • Educational Institutions
    • Online Platforms
    • Other Settings
    • Workplace/Corporate Programs

    US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BEHAVIORAL DISORDERS57.864.171.479.889.5100.9114.3130.412.6
    COGNITIVE DISORDERS3134.638.743.54955.563.272.413.1
    PHYSIOLOGICAL DISORDERS160.2176.2194.6215.6239.8267.9301.1340.411.6
    PSYCHIATRIC DISORDERS103.4112.3122.3133.6146.7161.7179.2199.910.1
    TOTAL352.4387.2427472.4525586657.874311.5

    Target Audience

    • Healthcare Providers & Hospital Systems : US hospitals and clinics need market data to justify investments in mental health screening infrastructure, understand adoption trends, and benchmark their screening programs against industry standards.
    • Mental Health Technology Vendors : Digital health companies and screening tool developers require US market insights to identify growth opportunities, understand customer needs, and develop solutions aligned with primary care integration trends.
    • Insurance & Managed Care Organizations : US insurers and managed care providers need market intelligence to evaluate screening program ROI, understand prevalence trends, and develop reimbursement policies that support early intervention.
    • Pharmaceutical & Diagnostic Companies : Pharma and diagnostic firms need US market data to assess demand for mental health treatments, identify screening-to-treatment pathways, and plan product launches and marketing strategies.
    • Healthcare Investors & Consultants : Investment firms and management consultants require detailed US market analysis to evaluate portfolio opportunities, assess company valuations, and provide strategic guidance to healthcare clients.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise US market valuation data ($176.23M in 2023) and verified forecasts through 2028, enabling accurate financial planning and investment decisions for mental health screening initiatives.
    • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, key players, and market positioning strategies to identify partnership opportunities and differentiation strategies in the rapidly expanding screening market.
    • Regional Growth Drivers Analysis : Gain insights into US-specific factors driving the 11.6% CAGR, including regulatory changes, insurance reimbursement trends, and primary care adoption patterns unique to the American healthcare system.
    • Strategic Market Segmentation : Access detailed breakdowns of the US market by screening type, end-user, and geography to identify high-growth segments and tailor product development and go-to-market strategies accordingly.
    • Risk Mitigation & Forecasting : Leverage comprehensive US market analysis to anticipate challenges, regulatory shifts, and emerging opportunities, reducing investment risk and improving strategic planning accuracy through 2028.

    Frequently asked questions

    What is the current size of the US mental health screening market?

    The US mental health screening market was valued at $176.23 million in 2023 and is expected to reach $340.35 million by 2028.

    What is the growth rate of the US mental health screening market?

    The US mental health screening market is growing at a compound annual growth rate (CAGR) of 11.6% from 2023 to 2028.

    What factors are driving growth in the US mental health screening market?

    Key drivers in the US include rising mental health awareness, increased prevalence of mental health disorders, integration of screening into primary care, favorable reimbursement policies, and expansion of digital health solutions.

    Which screening technologies are most prevalent in the US market?

    The US market includes both traditional paper-based screening tools and advanced digital platforms, with telehealth-based screening solutions experiencing rapid adoption.

    How is the US healthcare system supporting mental health screening adoption?

    The US healthcare system supports mental health screening through regulatory frameworks, workplace wellness programs, insurance reimbursement, and integration into preventive care initiatives.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Breakdown of Primary Interviews

    Health Screening Market Size, and Share

    Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Approach 1: Mental Health Screening Market (Revenue Share Analysis)

    • Revenues for individual companies were gathered from public sources and databases for each market segment.
    • Revenues of private companies were gathered through paid databases such as Factiva and Hoovers.
    • Shares of the mental health screening businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, and geographic reach.
    • Individual shares or revenue estimates were validated through expert interviews.
    • The market size was then extrapolated to obtain the global market. It was further validated through expert interviews.

    Approach 2: Segmental Extrapolation

    Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.

    • Mental health screening tools (excluding continuous monitoring wearable devices):
    • The total number of psychiatrists in the US was determined for 2022. The percentage of psychiatrists using mental health screening tools offered by vendors was identified through extensive secondary research and validated through insights from primary interviews.
    • The average price of mental health screening tools for yearly subscriptions was considered to arrive at the US mental health screening market for clinical settings in 2022.
    • Considering the share of clinical settings, revenues of the overall market in the US were determined for 2022.
    • The US mental health screening market was extrapolated to arrive at the global market.
    • The market for continuous monitoring wearable devices:
    • The total prevalence of mental health disorders in the US was determined for 2022, and the share of people opting for assessments was identified through extensive secondary research and validated through insights from primary interviews.
    • The share of people using continuous monitoring wearable devices for mental health screening was assumed based on secondary research and insights from primary interviews.
    • The average price of continuous monitoring wearable devices was determined through secondary sources to arrive at the US market for continuous monitoring wearable devices.
    • The US market for continuous monitoring wearable devices was extrapolated to arrive at the global market for continuous monitoring wearable devices.
    • The sum of revenues from mental health screening tools and continuous monitoring wearable devices used for mental health screening provided the revenue of the global mental health screening market. The assumptions at each step were validated through primary interviews.

    Approach 3: Primary Interviews

    • As a part of the primary research process, individual respondents’ insights on the market size and growth were taken during the interview (regional and global, as applicable).
    • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

    Data Triangulation:

    After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.

    Market Definition:

    Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

    Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.

    Key Stakeholders:

    • Manufacturers of mental health screening solutions/products
    • Suppliers and distributors of mental health screening solutions/products
    • Third-party refurbishers/suppliers
    • Clinical settings
    • Educational institutions
    • Group purchasing organizations (GPOs)
    • Academic medical centers and universities
    • Corporate entities
    • Community centers
    • Government institutes
    • Market research & consulting firms
    • Contract manufacturing organizations (CMOs)
    • Venture capitalists & investors

    Report Objectives

    • To define, describe, and forecast the mental health screening market by application, screening method, technology, age group, setting, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall mental health screening market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies
    • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments, such as partnerships, acquisitions, and launches
    • To benchmark players within the mental health screening market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Additional Company Profiling

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe mental health screening market into Spain, Italy, Russia, and others
    • Further breakdown of the Rest of Asia Pacific mental health screening market into Australia, South Korea, Singapore, and others

    Get the Full Mental Health Screening Market Report

    Full forecast, segment splits, and company analysis for all Mental Health Screening Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status